Expression of the cyclin dependent kinase inhibitor p27 KIP1 is intimately linked to the control of proliferation, and is itself regulated by transcription, translation, phosphorylation, protein stability or sequestration. p27 KIP1 is also regulated during apoptosis; cleavage occurs at DPSD 139 S and ESQD 108 V, by a sub-set of Z-VAD-fmk-sensitive caspases. We have identi®ed a related but distinct mechanism that regulates p27 KIP1 in proliferating lymphoid cell lines. In a B-lymphoid cell line (BJAB), the abundance of p27 KIP1 oscillates inversely to proliferation; loss of full-length p27 KIP1 correlates with the appearance of a truncated version corresponding to cleavage at DPSD 
, by virtue of its broad speci®city for cyclin/ CDK complexes, is a key regulator of the mammalian cell cycle (Mittnacht, 1998; Sherr and Roberts, 1999) . As a potent inhibitor of both cyclin E/CDK and cyclin A/CDK complexes, enforced expression of p27 KIP1 induces a G1 arrest. Accordingly, endogenous expression is generally inversely related to proliferative status (Polyak et al., 1994b; Toyoshima and Hunter, 1994) . Thus, whereas many types of proliferating cells express low levels of p27 KIP1 , this is increased by several growth-inhibitory treatments including TGFb, rapamycin and serum starvation (Kawamata et al., 1998; Luo et al., 1996; Nourse et al., 1994; Polyak et al., 1994a) . Conversely, p27 KIP1 is generally down-regulated following stimulation with growth factors or mitogens (reviewed in Sherr and Roberts, 1995) . Similarly the high level of p27 KIP1 present in quiescent B lymphocytes is markedly reduced following treatment with phorbol esters or infection with Epstein-Barr virus (Cannell et al., 1996; Spender et al., 1999) . The eects of p27 KIP1 in cultured cells are re¯ected by its eects in whole animals; p27 KIP1 -null mice display growth abnormalities Nakayama et al., 1996) , while p27 KIP1 is a haploinsucient tumour suppressor in heterozygous animals (Fero et al., 1998) . In human cancers reduced expression of p27 KIP1 generally correlates with aggressive tumours and is an indicator of poor prognosis (Catzavelos et al., 1997; Fredersdorf et al., 1997; Loda et al., 1997; Porter et al., 1997) .
It has recently emerged that the abundance of p27 KIP1 is down-regulated in cells undergoing apoptosis, and furthermore that alteration in p27 KIP1 expression may be relevant to the apoptotic process. However, depending on cell type or apoptotic stimulus, p27 KIP1 can produce either pro-or anti-apoptotic eects (Craig et al., 1997; Eymin et al., 1999a ,b Hiromura et al., 1999 Park et al., 1998; Schreiber et al., 1999; Wang et al., 1997) . Interestingly, CDK2 activity is necessary for certain manifestations of apoptosis including chromatin condensation, cell shrinkage and loss of adhesion in HeLa cells treated with staurosporine or TNFa (Harvey et al., 2000) .
Bearing in mind the central role of p27 KIP1 in controlling cell proliferation, as well as its complex involvement in cell death, it is maybe not surprising that expression of this protein is tightly regulated. Both translational and transcriptional changes occur (Agrawal et al., 1996; Hengst and Reed, 1996; Kawamata et al., 1998; Kwon et al., 1996 Kwon et al., , 1997 Millard et al., 1997) , but most commonly the expression of p27 type cyclins (Barnouin et al., 1999; Polyak et al., 1994a; Poon et al., 1995; Reynisdottir et al., 1995; Sherr and Roberts, 1999; Soos et al., 1996) or by an unidenti®ed protein induced by elevations in c-myc (Vlach et al., 1996) . A second mechanism is by degradation by the proteasome, which requires prior covalent modi®cation of p27 KIP1 with ubiquitin (Pagano et al., 1995) . There is evidence that in order for p27 KIP1 to become a target for ubiquitination it must ®rst be phosphorylated on threonine 187 by cyclin E-associated CDK2 (Montagnoli et al., 1999; Morisaki et al., 1997; Nguyen et al., 1999; Shea et al., 1997; Vlach et al., 1997) .
At least two mechanisms are involved in the regulation of p27 KIP1 during apoptosis of lymphoid cells (Frost and Sinclair, 2000) . Similar to observations made in endothelial cells and monocytic leukaemia cells (Eymin et al., 1999a,b; Levkau et al., 1998) , we found that Fas-induced apoptosis in lymphoid cells is associated with caspase-dependent down-regulation of p27
KIP1
, and this was inhibited by the broad spectrum caspase inhibitor Z-VAD-fmk. A second, Z-VAD-fmkindependent mechanism is responsible for the downregulation of p27 KIP1 that occurs in lymphoid cells treated with the apoptotic agents etoposide and cycloheximide (Frost and Sinclair, 2000) . Both p27 KIP1 and its relative p21 CIP1 undergo direct cleavage by caspase-3 (CPP32) or a caspase-3-like enzyme in apoptotic endothelial cells (Levkau et al., 1998) . Cleavage occurs at a consensus caspase site (DPSD 139 S) to produce a C-terminally truncated version of p27 KIP1 that migrates with an apparent molecular weight of 22 ± 23 kDa on polyacrylamide gels. Cleavage was inhibited by z-VAD-fmk. Subsequent studies in etoposide-treated U-937 monocytic leukaemia cells revealed an additional caspase site (ESQD 108 V) giving rise to a 15 kDa C-terminally truncated protein. Again both cleavage events were inhibited by Z-VAD-fmk (Eymin et al., 1999b) . In the aforementioned study, both truncated versions of p27 KIP1 , like the wild type protein, were demonstrated to suppress apoptosis when overexpressed ectopically. Interestingly it has recently been shown that Z-VAD-fmk-and Ac-DEVD-CHO-sensitive caspases are involved in the regulation of p27 KIP1 in growth-arrested hybridoma and myeloma cell lines (Loubat et al., 1999) , suggesting an additional role for caspase-like enzymes in the regulation of p27 KIP1 in the absence of, or prior to, apoptosis.
In this paper we implicate a caspase in the proliferation-associated regulation of the cyclin dependent kinase inhibitor p27 KIP1 in non-apoptotic BJAB cells. Caspase activity correlates with the expression of a C-terminally truncated form of p27 
Results

p27
KIP1 is associated with cdk2 in growth-arrested BJAB cells During our studies of p27 KIP1 regulation in B-lymphoid cell lines we investigated whether or not the Blymphoma cell line BJAB contained functional p27
KIP1
. Thus immunoprecipitations were carried out to determine whether or not p27 KIP1 could be detected in a complex with its inhibitory target, cdk2, in extracts from growth-arrested BJAB cells. Puri®cation of p27 KIP1 from the extracts using an antibody directed against its C-terminus resulted in co-puri®cation of cdk2 (Figure 1 ), thus indicating that p27 KIP1 forms an inhibitory complex with cdk2 in growth-arrested BJAB cells. The ®nding that p27 KIP1 is expressed and functional in BJAB cells lead us to investigate the relationship between p27 KIP1 regulation and proliferation in these cells.
The abundance of p27
KIP1 in BJAB cells is regulated in a proliferation-related manner, potentially by caspases We then asked whether or not p27 KIP1 expression showed the same cell cycle¯uctuations in B-cells as has been observed in other cell types. In order to compare KIP1 is associated with cdk2 in growth-arrested BJAB cells. BJAB cells were diluted to 2610 5 cells/ml and incubated for 6 days, by which time the cultures were saturated and the cells growth arrested. NP40 extracts were prepared and immunoprecipitated with either non-speci®c rabbit immunoglobulin (NS) or rabbit anti-p27 KIP1 (C19). Mock immunoprecipitations carried out in the absence of extract were performed in parallel. Immunoprecipitated proteins derived from 1.7610 6 cells were run alongside crude extract (total) on 15% polyacrylamide gels, subjected to Western blotting and probed with polyclonal antisera recognizing cdk2 (M2) conditions of proliferation and arrest, BJAB cells were ®rst diluted and then allowed to saturate over an 8 day period. One day after dilution the cells were actively proliferating as demonstrated by the incorporation of radioactive thymidine into DNA (Figure 2a ). The abundance of p27 KIP1 was very low in these cells, and was not readily detected with the antiserum raised to the C-terminus of the protein on this Western blot (Figure 2b ). However, expression of p27 KIP1 increased to readily detectable levels with time, showing a dramatic up-regulation at times when the cells were fully arrested (5 ± 8 days) (Figure 2a,b) . Thus in common with many other cell types,¯uctuations in p27 KIP1 abundance are a feature of altered growth state in BJAB cells.
Clues to the mechanism responsible for the proliferation-related down-regulation of p27 KIP1 in BJAB cells emerged when extracts from growing and arrested cells were probed with an antiserum raised against the N-terminus (amino acids 2 ± 21) of p27 KIP1 (N20). Using this antibody a second immunoreactive band was detected whose abundance was inversely proportional to that of the full length p27 KIP1 protein (Figure 2b ). The migration and immunoreactivity of this second species is consistent with it being a cleavage product of p27 KIP1 missing the carboxyl terminal third. This suggests that proliferation-associated changes in p27 KIP1 abundance in BJAB cells might be mediated by cleavage of the protein. To con®rm the identity of this protein we compared the reactivity with an antibody previously shown to recognize a C-terminally truncated form of p27 KIP1 in other cells, clone 57 (Eymin et al., 1999b; Figure 2c bands in the BJAB extract was detected using the N-terminal p27 KIP1 antiserum (N20). The ®lters were realigned and the migration of the bands compared and this site is used in endothelial cells and myeloid leukaemia cells undergoing apoptosis (Eymin et al., 1999a,b; Levkau et al., 1998) . Furthermore, p27 KIP1 has been shown to be susceptible to caspase-dependent cleavage in non-apoptotic mouse hybridoma and human myeloma cells, although in this study the caspase activity increased during conditions of growth arrest (Loubat et al., 1999) . In the above studies, cleavage of p27 KIP1 occurred after D
139
, resulted in the production of a 22 ± 23 kDa, C-terminally truncated protein. Removal of the C-terminus of p27 KIP1 has no eect on its ability to bind and inhibit cdks in vitro, but importantly it impairs nuclear localization in vivo (Levkau et al., 1998; Loubat et al., 1999) . This suggests that the 23 kDa species is non-functional as a cdkI.
In KIP1 which were fractionated on a gel and blotted with BJAB cell extracts. The ®lter was then processed and re-aligned. Translation of the recombinant p27 KIP1 proteins showed several species of radioactive protein, some of which may be derived from the vector backbone or from translation of residual reticulocyte mRNAs. However additional species were detected, one at approximately 27 kDa and one alongside the 17.5 kDa coloured standard, which represent full length p27 KIP1 and p27
KIP1
S140ter respectively ( Figure 2d ). Since the molecular weight of p27 KIP1 S140ter did not correlate exactly with previously published data (22 ± 23 kDa), it was more accurately determined using radiolabelled standards and was found to indeed migrate at 22 ± 23 kDa (not shown). Figure 2d shows that the two forms of p27 KIP1 present in growing BJAB cells co-migrate with recombinant full length p27 KIP1 and p27 KIP1 S140ter, suggesting that p27 
Proliferation-related caspase activation is not coupled to apoptosis
It was possible that the proliferation-associated cleavage of p27 KIP1 in BJAB cells was actually due to a higher basal level of apoptosis, and hence caspase activation, in proliferating cell populations relative to arrested populations. Thus we measured the activity of the apoptosis-related eector caspase, caspase-3, in extracts from proliferating BJAB cells using a¯uoro-genic caspase-3 substrate (Ac-DEVD-AMC), and compared this with the activity present in BJAB cells treated with an agonistic Fas antibody ( Figure 3a) . As expected a 5 h treatment with Fas antibody resulted in a high level of DEVD-cleaving activity in BJAB cells, whereas extracts from exponentially growing BJAB cells contained a comparatively low basal level of Ac-DEVD-AMC cleaving activity. Furthermore, comparison of the extent of DEVD-cleavage by extracts from proliferating and arrested BJAB cells revealed that caspase-3 (or caspase-3-like) activity was actually greater in the arrested cells that exhibit a high ratio of the 27 to 23 kDa species (Figure 3b ). This conclusion was con®rmed by measurement of the surface expression of phosphatidylserine as an early marker of apoptosis using Annexin-V-¯uorescein staining and FACS analysis of live cell populations. Proliferating BJAB cells contain a single population of cells with low Annexin-V staining (Figure 3c ), consistent with the basal levels of surface phosphatidylserine expression seen in other growing cell populations (data not shown). This population was also represented in the arrested cultures, along with an extra population of more strongly annexin-V positive cells. Quanti®ca-tion of the proportion of strong annexin-V-positive cells in the proliferating and arrested cultures revealed that while only 11% of the proliferating population were designated strong positives, 33% of the arrested population were strongly positive for annexin-V. Hoechst staining failed to identify any late apoptotic cells in either proliferating or arrested cultures (data not shown), suggesting that apoptosis had not proceeded further than the early stages, even in the arrested cells. Thus the inverse relationship in proliferating and arrested cells between surface expression of phosphatidylserine and caspase-3 activity on one hand, and p27 KIP1 cleavage on the other, strongly suggests that the p27 KIP1 -directed caspase activity in BJAB cells is linked to proliferation as opposed to apoptosis.
BJAB cells contain caspase or caspase-like activities that are inversely regulated with respect to p27 KIP1 abundance
In order to discover whether or not BJAB cells contained a caspase-like activity that could be responsible for the dierent extent of p27 KIP1 -cleavage seen in proliferating and arrested cells, we carried out in vitro cleavage assays on a panel of¯uorogenic caspase substrates (Ac-YVAD-AMC, Ac-IETD-AMC, Ac-LEHD-AMC). Proliferating BJAB cells contained an activity that was capable of inducing a 10-fold increase in the cleavage of the tetrapeptide substrate Ac-IETD-AMC relative to a control lacking cell extract (Figure 4a ). Furthermore, activity was reduced almost to control levels in extracts from arrested cells. Ac-IETD-AMC is frequently used to measure caspase-8 activity, suggesting that the activity present in BJAB cells is caspase-8-like in terms of substrate speci®city. However, it is known that the speci®city of caspase family members for tetrapeptide substrates overlaps (Talanian et al., 1997; Thornberry et al., 1997) , and indeed the caspase-1 substrate (Ac-YVAD-AMC) also shows a high degree of cleavage in the presence of extract from proliferating cells. Again, the cleaving activity was greatly reduced in extracts from arrested cells. The caspase-9 substrate (Ac-LEHD-AMC) showed only a small amount of cleavage in the presence of growing BJAB extract. At present it is not clear whether these cleavage events re¯ect the presence of multiple caspase activities in growing BJAB cells, or whether a single caspase is responsible that has a low For each substrate a control containing all components of the assay except extract was included (7). (b) Extract prepared in the presence of protease inhibitors from exponentially growing BJAB cells (E) was tested for its ability to cleave Ac-IETD-AMC in the presence of the selective inhibitor Ac-IETD-CHO as indicated speci®city for Ac-LEHD-AMC, and a much higher speci®city for Ac-YVAD-AMC and Ac-IETD-AMC. In all cases proliferating cells contained more tetrapeptide cleaving activity than their arrested counterparts.
The speci®city of the IETD-cleaving activity was challenged using the selective inhibitor Ac-IETD-CHO (Figure 4b) . Inclusion of this inhibitor abrogated the cleavage of Ac-IETD-AMC by extract from proliferating BJAB cells. Taken together, these observations suggest that a caspase-like enzyme(s) drives proliferation-associated changes in p27 KIP1 abundance, further extending the non-apoptotic role of caspases.
Caspase-8 is not required for the proliferation dependent cleavage of p27
KIP1
Since the proliferation-regulated caspase activity present in BJAB cells was particularly ecient at cleaving the caspase-8 substrate Ac-IETD-AMC, we investigated whether the activity is caspase-8 itself. In order to test this possibility we compared the caspase activity and levels of full length p27 KIP1 in control Jurkat A3 cells and a caspase-8-de®cient cell line, Jurkat 9.2 (Juo et al., 1998) . This analysis showed that the proliferation-associated caspase activity is not restricted to Blymphoid cells but was also detected in the T-lymphoid Jurkat A3 cell line (Figure 5a ). Furthermore, proliferating caspase-8-de®cient Jurkat 9.2 cells showed similar levels of IETD-cleaving activity as the wild type Jurkat A3 cells, and in both cases this was abrogated by the selective inhibitor Ac-IETD-CHO (Figure 5a ). In accord with these observations, levels of full length p27 KIP1 were equivalent in the wild type and caspase-8-de®cient cell line (Figure 5b ). In addition, Western blotting with the N-terminal p27 KIP1 antibody revealed that high levels of the cleaved form of p27 KIP1 were present in both the wild type and caspase-8-de®cient cell line (Figure 5c ). Taken together, this supports the notion that caspase-8 is not required for the proliferation-associated cleavage of p27 KIP1 in lymphoid cells.
The caspase activity(s) present in proliferating BJAB cells is insensitive to z-VAD-fmk added in vivo or in vitro
As previously mentioned, p27 KIP1 has been shown to undergo cleavage by caspases in other cell types, either during apoptosis or less commonly during growth arrest (Eymin et al., 1999a,b; Levkau et al., 1998; Loubat et al., 1999) . In all cases these cleavage events could be inhibited by the broad spectrum caspase inhibitor Z-VAD-fmk. However, the involvement of Z-VAD-fmk-sensitive caspase(s) in apoptosis-induced p27 KIP1 down-regulation is not universal as in etopo- . (a) Extracts from exponentially growing Jurkat A3 cells (wt) and caspase-8-de®cient Jurkat 9.2 cells (m) were tested for their ability to cleave the¯uorescent caspase substrate Ac-IETD-AMC in the absence or presence of Ac-IETD-CHO. B, C. Extracts were prepared from exponentially growing Jurkat A3 cells and caspase-8-de®cient Jurkat 9.2 cells and used for Western blotting. p27 KIP1 was detected using polyclonal antisera that recognize the C-terminus (C-19; b) or the N-terminus (N20; c) of the protein side-and cycloheximide-treated Jurkat T-cells, p27 KIP1 expression is decreased in a Z-VAD-fmk-insensitive manner (Frost and Sinclair, 2000) . Resistance to Z-VAD-fmk is also displayed by the MDM2-directed caspase activity present in non-apoptotic tumour cells (Pochampally et al., 1999) . Furthermore, not all known caspases are inhibited by Z-VAD-fmk; caspase-2 is particularly insensitive to this agent (Garcia-Calvo et al., 1998). Therefore we asked whether the low levels of p27 KIP1 expressed in growing BJAB cells could be increased by treatment with Z-VAD-fmk. Addition of Z-VAD-fmk to BJAB cells had little eect on the amount of full length or cleaved p27 KIP1 detected with the N-terminal p27 KIP1 antiserum (Figure 6b ). The ecacy of Z-VAD-fmk as a caspase inhibitor in BJAB cells was con®rmed by its ability to inhibit Fas-induced PARP cleavage in these cells (Frost and Sinclair, 2000) .
The lack of eect of Z-VAD-fmk on p27 KIP1 expression in BJAB cells in vivo lead us to examine the eects of the inhibitor in vitro. In keeping with our observations in vivo, addition of Z-VAD-fmk directly to caspase assays performed with proliferating BJAB cell extract had no eect on the extent of cleavage of any of the three caspase substrates (Figure 6b) .
The ecacy of Z-VAD-fmk as an inhibitor of caspases in vitro was con®rmed in an IETD-cleavage assay using extracts from Jurkat A3 T-cells treated with an agonistic Fas antibody. Stimulation of the Fas receptor in these cells is known to signal through caspase-8 to induce apoptosis (Juo et al., 1998) . As previously shown, growing Jurkat A3 T-cells, like BJAB cells, contain an IETD-cleaving activity, indicating that a proliferation-associated caspase activity is present in T-cell as well as B-cell lineages. Fas- Figure 6 The caspase activity(s) present in growing BJAB cells is insensitive to Z-VAD-fmk added in vivo or in vitro. (a) Z-VADfmk was added to exponentially growing BJAB cells for 24 h and extracts prepared for Western blotting. The membrane was probed with a polyclonal antiserum recognizing the N-terminus of p27 KIP1 (N20). (b) Extract prepared in the presence of protease inhibitors from exponentially growing BJAB cells was tested for its ability to cleave the¯uorescent caspase substrates Ac-YVAD-AMC, Ac-IETD-AMC and Ac-LEHD-AMC in the absence or presence of Z-VAD-fmk. (c). Extracts from exponentially growing (E) or anti-Fas-treated (F) Jurkat A3 cells were compared for their ability to cleave the¯uorescent caspase substrate Ac-IETD-AMC in the presence of Z-VAD-fmk treatment of the Jurkat A3 T-cells increased the IETD cleavage (Figure 6c) . Interestingly, whereas Z-VADfmk added in vitro had no eect on the IETD-cleaving activity present in untreated proliferating cells, the Fasinduced rise in IETD-cleaving activity was completely abrogated by Z-VAD-fmk. This is in keeping with previous reports showing that recombinant active caspase-8 is inhibited by Z-VAD-fmk in vitro (GarciaCalvo et al., 1998) . The dierential Z-VAD-fmksensitivity of the IETD-cleaving activity induced by Fas-stimulation and the activity detected in proliferating cells con®rms that the two activities are dierent. Indeed the resistance of the proliferation-associated caspase to Z-VAD-fmk distinguishes it from most known caspases. Furthermore, it appears that the caspase activity present in proliferating cells accounts for approximately two-thirds of the total IETDcleaving activity present in Fas-ligated cells, suggesting that the level of caspase activity present in growing lymphoid cells is likely to be physiologically relevant.
The proliferation-associated caspase in BJAB cells cleaves a substrate based on DPSD 139 but not ESQD
108
The caspase activity present in proliferating BJAB cells was characterized further using custom made¯uoro-genic substrates based on the two potential sites of caspase cleavage in p27 KIP1 (Ac-DPSD-AMC and Ac-ESQD-AMC) (Figure 7a ). Using three sets of independently prepared extracts, the extent of cleavage of Ac-DPSD-AMC resembled that of Ac-IETD-AMC; activity against both substrates was at least fourfold higher in the extracts from proliferating cells compared with arrested cell extracts. In contrast the substrate Ac-ESQD-AMC which is a second caspase recognition site in p27 KIP1 (Eymin et al., 1999b) was resistant to cleavage, either by extracts from proliferating or arrested BJAB cells. This agrees with the lack of a second cleavage product on Western blots of BJAB extracts using the N-terminal p27 KIP1 antibodies (Figures 2b,c) . The similarity between the characteristics of the IETD-and DPSD-cleaving activities suggests that they represent the same caspase. Indeed the DPSD-cleaving activity was also resistant to Z-VAD-fmk, but was greatly reduced by the inhibitor Ac-IETD-CHO (Figure 7b ).
Inhibition of caspase(s) in vivo with Z-IETD-fmk results in an increase in the expression of p27 KIP1 and a reduction in cell proliferation
As the DPSD-cleaving activity present in extracts from proliferating BJAB cells was inhibited by the caspase inhibitor Ac-IETD-CHO, we used a cell permeable version of this inhibitor, Z-IETD-fmk, to determine whether inhibition of the DPSD-cleaving activity in vivo aected expression of p27 
Discussion
p27
KIP1 is a key regulator of the mitotic cycle in mammalian cells and its expression in many dierent cell types correlates inversely with growth (Sherr and Roberts, 1999 ). An inverse correlation between p27 KIP1 expression and malignancy exists in several human cancers including breast, colorectal, gastric and small cell lung carcinomas (Barnouin et al., 1999; Fredersdorf et al., 1997) . The prognostic value of p27 KIP1 in human B-cell lymphomas has previously been investigated and revealed that while an inverse correlation exists generally between the expression of p27 KIP1 and the degree of malignancy of B-cell lymphomas, a subset of Burkitt's lymphoma cells display unusually high expression of p27 KIP1 (Barnouin et al., 1999) . The high level of p27 KIP1 expression in these cells is coupled to a high level of cyclin D3 expression, and furthermore complexes of cyclin D3/cdk4 can sequester the growth inhibitory activity of p27 KIP1 . However, our observation that p27 KIP1 is associated with cdk2 in growth-arrested BJAB cells indicates that sequestration of p27 KIP1 away from its inhibitory target cdk2 is not a universal phenomenom in B-lymphomas. Instead, we have described an apparently novel p27 KIP1 -directed caspase activity, which is able to regulate the expression of p27 KIP1 in non-apoptotic lymphoid cells. The lack of sensitivity of the caspase to the broad spectrum caspase inhibitor Z-VAD-fmk distinguishes it from many caspases that are traditionally associated with apoptosis including 1,3,5,7,8 and 9 (Ekert et al., 1999; Garcia-Calvo et al., 1998) . However, Z-VAD-fmk is not a universal inhibitor of caspases; second order inactivation rates (k) determined for this agent vary dramatically between caspases, ranging from a potent inhibition of caspases-1 and -8 (k=2.8610 5 m 71 s
71
) to a poor inhibition of caspase-2 (k=2.9610 2 m 71 s
) (GarciaCalvo et al., 1998). All previous reports of p27 KIP1 cleavage were inhibited by Z-VAD-fmk, indicating that the p27
KIP1
-cleaving activity present in non-apoptotic BJAB cells is dierent from those previously described. Interestingly, recent studies in our laboratory showed that the further down-regulation of p27 KIP1 that occurs in lymphoid cells promoted to apoptose by exposure to etoposide or cycloheximide is also insensitive to Z-VAD-fmk (Frost and Sinclair, 2000) . However, in these experiments the down-regulation of p27 KIP1 failed to correlate with accumulation of a cleaved form of p27 KIP1 , suggesting either that the cleaved form was unstable in cells treated in this way, or loss of p27 KIP1 in response to these agents does not involve direct cleavage by caspases.
The optimal substrate speci®cities of caspase family members has been analysed by both a combinatorial approach and using de®ned peptide sequence variants, Extract prepared in the presence of protease inhibitors from exponentially growing BJAB cells (E) was tested for its ability to cleave Ac-DPSD-AMC in the presence of the inhibitors Ac-IETD-CHO (C) or Z-VAD-fmk (Z). In all cases background measurements generated from reactions completed in the absence of either extract or substrate were subtracted from experimental values Hthymidine to measure cell proliferation. Error bars represent standard deviation and this has allowed the allocation of caspases into three distinct groups (Nicholson, 1999; Talanian et al., 1997; Thornberry et al., 1997) . The caspase recognition site in p27 KIP1 (DPSD) most resembles a type II site, which is generally preferred by caspases 2, 3 and 7. However, the presence of proline at position 3, argues against any of these group II caspases being the physiological executor of p27 KIP1 cleavage, as combinatorial chemistry has revealed poor recognition of substrates containing proline at position 3 by these caspases (Thornberry et al., 1997) . In fact, all nine caspases surveyed in the aforementioned study (caspases 1 ± 9) exhibited poor speci®city to tetrapeptide substrates containing a proline at position 3, suggesting that the p27 KIP1 -directed caspase(s) may represent new member(s) of the growing family of caspases.
Apoptosis-independent roles for caspases are now well established and include the involvement of group I (ICE-like) caspases in cytokine processing and in¯am-mation. Even group II caspases which have a substrate speci®city consistent with many apoptosis-related substrates (DEXD), may function outside of the apoptotic pathway (Zeuner et al., 1999) . For example, a role for caspase-3 or caspase-3 like enzymes in the processing of IL-16 in T cells, and IL-18 in monocytic cells had been suggested (Akita et al., 1997; Wu et al., 1999; Zhang et al., 1998) . Pertinently, caspase activation is an early event following stimulation of quiescent T-and B-lymphocytes, and occurs in the absence of apoptosis (Alam et al., 1999; Kennedy et al., 1999; Miossec et al., 1997; Wilhelm et al., 1998) . Furthermore, a requirement for caspases in the activation of T lymphocytes has been demonstrated (Alam et al., 1999; Kennedy et al., 1999) . The caspase inhibitor Z-VADfmk can inhibit a variety of activation-associated events in lymphocytes including CD3-induced proliferation, IL-2 production, MHC class II expression, and blastic transformation (Alam et al., 1999; Kennedy et al., 1999) . Caspase-8 was processed in the activated T lymphocytes, and this was often but not always coupled with activation of downstream caspases including caspase-3. However, identi®cation of the exact caspase(s) required for the activation process, and its substrate(s), remains to be elucidated. The dierential sensitivity to Z-VAD-fmk clearly distinguishes the caspase activity present in proliferating BJAB cells from the caspase activities described in activated primary lymphocytes. However, bearing in mind the key role of p27 KIP1 in controlling cell cycle progression, it would be pertinent to explore the contribution of p27 KIP1 cleavage to the activation of quiescent lymphocytes.
As the caspase activity present in non-apoptotic BJAB cells is proliferation-associated it is likely that it will contribute to cell cycle associated changes in p27 KIP1 abundance observed in these cells. Indeed, inhibition of the activity in vivo using Z-IETD-fmk promoted an increase in full length p27
. Interestingly, another regulatory protein of the mammalian cell cycle, MDM2 undergoes caspase-dependent cleavage at the site DVPD 361 in tumour cells, in the absence of as well as during apoptosis (Chen et al., 1997; Erhardt et al., 1997; Pochampally et al., 1998 Pochampally et al., , 1999 . Similar to our observations in BJAB cells, dierent characteristics were exhibited by the MDM2-cleaving activity in apoptotic and non-apoptotic cells. Whereas, MDM2 is cleaved by caspase-3 in a Z-VAD-fmksensitive manner in apoptotic cells, and this is accompanied by cleavage of another caspase-3 substrate PARP, the cleavage of MDM2 that occurs in non-apoptotic cells failed to correlate with PARP cleavage and was only partially inhibited by Z-VADfmk. Thus, it is becoming increasingly likely that caspases, in addition to their established roles in apoptosis, lymphokine processing and in¯ammation, may also contribute to cell cycle decisions. The description of another mechanism by which p27 KIP1 can be regulated in mammalian cells, underlines the importance of this inhibitor of CDKs in growth control.
Materials and methods
Caspase-3 substrate (Ac-DEVD-AMC) was obtained from Pharmingen. Caspase-1 substrate (Ac-YVAD-AMC), caspase-8 substrate (Ac-IETD-AMC) and inhibitor (Ac-IETD-CHO) were obtained from BioMol. Caspase-9 substrate (Ac-LEHD-AMC) was obtained from Alexis. Substrates and inhibitors were dissolved in 4% v/v DMSO. Z-VAD-fmk was obtained from Calbiochem and Z-IETD-fmk was obtained from BioVision Research products; both were dissolved in DMSO. Rabbit polyclonal antisera recognizing the Cterminus (C19), or the N-terminus (N20) of human p27 KIP1 , or human cdk2 (M2) were from Santa Cruz. Mouse monoclonal antibody recognizing human p27 KIP1 (Clone 57) was from Transduction Laboratories.
Cell culture BJAB B-lymphoblastoid cells (Clements et al., 1975) , Jurkat A3 T-lymphoblastoid cells and their caspase-8-de®cient derivative, Jurkat 9.2 (Juo et al., 1998) were grown in RPMI supplemented with 10% heat-inactivated foetal calf serum, 2 mM glutamine and 100 IU/ml penicillin/streptomycin (Sinclair et al., 1994) . Where indicated Z-VAD-fmk (50 mM), Z-IETD-fmk (2 mM) or an equivalent amount of DMSO was added to exponentially growing cells.
Immunoprecipitation
BJAB cells were diluted to 2610
5 cells/ml and incubated for 6 days, to allow the culture to saturate and cell proliferation to cease. Cells were washed in PBS and lysed in NP40 lysis buer (50 mM HEPES, 1% v/v NP40, 0.1% v/v Tween 20, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM NaF, 10% glycerol, pH 8.0). Debris was removed by centrifugation and the resultant extract pre-cleared with protein ASepharose. Cleared extract derived from 6.7610 6 cells was used in each immunoprecipitation with either 4 mg of nonspeci®c rabbit immunoglobulin or anti-p27 KIP1 (Santa Cruz, C19). Antibody-protein complexes were collected with protein A-Sepharose, and washed extensively with NP40 lysis buer. Following a ®nal wash with 50 mM Tris, pH 7.5, proteins were eluted from the Sepharose beads by boiling in SDS sample buer in the absence of reducing agents (4% w/v SDS, 20% v/v glycerol, 100 mg/ml bromophenol blue, 0.12 M Tris-HCl, pH 6.8). The abundance of cdk2 in the immunoprecipitated protein derived from 1.7610 6 cells was detected by Western blotting using anti-cdk2 (M2) as the primary antibody.
Western blotting
Cells were washed with PBS, lysed in SDS sample buer (4% w/ v SDS, 20% v/v glycerol, 2% v/v b-mercaptoethanol, 100 mg/ ml bromophenol blue, 0.12 M Tris-HCl, pH 6.8) and heated for 5 min at 958C. Extracts, equalized for cell number, were electrophoresed on 15% SDS-polyacrylamide gels. Proteins were transferred to PVDF membrane, and the membrane was ®xed, blocked and probed with primary antibodies as previously described (Cannell et al., 1998) . HRP-conjugated, species-speci®c secondary antibodies and ECL (Amersham) were used to visualize the signal (Cannell et al., 1998) .
Estimation of DNA synthesis
Viable cells were counted with Trypan blue, and triplicate aliquots (200 ml) were incubated with 2.5 mCi/ml 
Site-directed mutagenesis and in vitro translation
A vector encoding truncated p27 KIP1 (Bluescript-p27 KIP1-S140ter) was produced from a vector containing the full length human p27 KIP1 coding sequence (Polyak et al., 1994b ) using a QuickChange site directed mutagenesis kit (Stratagene). Primers used in the procedure, which involved insertion of a stop codon after position D
139
, were 5'-gatccgtcggactaacagacggggtta-3' and 5'-aaccccgtctgttagtccgacggatc-3'. Coupled transcription and translation of these vectors was carried out in vitro using TNT reticulocyte lysate (Promega).
Annexin-V staining and FACS analysis
Apoptosis was quanti®ed using the Annexin-V-FLUOS staining kit (Boehringer Mannheim) and FACS analysis undertaken according to the manufacturer's instructions. The amount of cell-surface associated Annexin-V-¯uorescein in a population of live cells was quanti®ed with a FACS Calibur (Becton Dickinson) using an excitation wavelength 488 nm with a 515 nm bandpass ®lter.
Caspase assays
Extract preparation and¯uorogenic caspase assays were carried out based on the method supplied with the caspase-3 assay kit (Pharmingen), although buer recipes were modi®ed to include inhibitors of serine-, aspartic-and metalloproteases as indicated. Brie¯y, cells were washed with PBS and lysed (1610 7 cells/ml) in cold lysis buer (130 mM NaCl, 1% Triton X-100, 10 mM NaPPi, 10 mM Tris-HCl, 1 mM EDTA, 1 mM PMSF, 0.25 mg/ml pepstatin A, 10 mM NaH 2 PO 4 /Na 2 HPO 4 , pH 7.5). Debris was removed from the resultant extracts by centrifugation. Caspase assays were carried out in 96 well plates by mixing 50 ml of extract with 200 ml reaction buer (10% glycerol, 2 mM DTT, 1 mM EDTA, 1 mM PMSF, 0.25 mg/ml pepstatin A, 200 mM HEPES, pH 7.5 and 25 mg/ml tetrapeptide-AMC substrate). The caspase inhibitors Ac-IETD-CHO (2 mg/ml) and Z-VADfmk (3 mM) were also added where indicated. Reactions were allowed to proceed for between 1 and 2 h at 378C. Measurement of AMC liberated from the tetrapeptide-AMC substrates was carried out using a SpectraMax Gemini spectro¯uorometer (Molecular Devices) with an excitation wavelength of 380 nm and an emission wavelength of 440 nm. Background measurements generated from the reaction completed in the absence of substrate were assessed and subtracted from experimental values.
Induction and inhibition of apoptosis
Apoptosis was induced with an agonistic anti-human Fas mouse monoclonal antibody (Upstate Biotechnology) as described previously (Frost and Sinclair, 2000) . Exponentially growing cells were pelleted and resuspended at 1/10 of their original volume in PBS (4610 6 cells/ml). Anti-Fas antibody was added to a ®nal concentration of 0.5 mg/ml and the cells incubated on ice for 30 min. The cells were then pelleted, restored to 4610 5 cells/ml in their original medium and incubated for 2 ± 5 h before harvesting. Where indicated Z-VAD-fmk (50 mM) was added with the anti-Fas antibody for the entire incubation period.
